Literature DB >> 25436557

Cyclin A2: a genuine cell cycle regulator?

Nawal Bendris, Abdelhalim Loukil, Caroline Cheung, Nikola Arsic, Cosette Rebouissou, Robert Hipskind, Marion Peter, Bénédicte Lemmers, Jean Marie Blanchard.   

Abstract

Abstract Cyclin A2 belongs to the core cell cycle regulators and participates in the control of both S phase and mitosis. However, several observations suggest that it is also endowed with other functions, and our recent data shed light on its involvement in cytoskeleton dynamic and cell motility. From the transcription of its gene to its posttranslational modifications, cyclin A2 regulation reveals the complexity of the regulatory network shaping cell cycle progression. We summarize our current knowledge on this cell cycle regulator and discuss recent findings raising the possibility that cyclin A2 might play a much broader role in epithelial tissues homeostasis.

Entities:  

Year:  2012        PMID: 25436557     DOI: 10.1515/bmc-2012-0027

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  16 in total

1.  Cyclin A2 regulates symmetrical mitotic spindle formation and centrosome amplification in human colon cancer cells.

Authors:  Jun-An Li; Bai-Chun Liu; Ying Song; Xin Chen
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 2.  Cyclin A2: At the crossroads of cell cycle and cell invasion.

Authors:  Abdelhalim Loukil; Caroline T Cheung; Nawal Bendris; Bénédicte Lemmers; Marion Peter; Jean Marie Blanchard
Journal:  World J Biol Chem       Date:  2015-11-26

3.  Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer.

Authors:  Yuchen Guo; Monica Gabola; Rossano Lattanzio; Conception Paul; Valérie Pinet; Ruizhi Tang; Hulya Turali; Julie Bremond; Ciro Longobardi; Chloé Maurizy; Quentin Da Costa; Pascal Finetti; Florence Boissière-Michot; Benjamin Rivière; Céline Lemmers; Séverine Garnier; François Bertucci; Inti Zlobec; Karim Chebli; Jamal Tazi; Rania Azar; Jean-Marie Blanchard; Peter Sicinski; Emilie Mamessier; Bénédicte Lemmers; Michael Hahne
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

4.  Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas.

Authors:  Melanie Haas Kucherlapati
Journal:  Cell Cycle       Date:  2022-04-19       Impact factor: 5.173

5.  Foci of cyclin A2 interact with actin and RhoA in mitosis.

Authors:  Abdelhalim Loukil; Fanny Izard; Mariya Georgieva; Shaereh Mashayekhan; Jean-Marie Blanchard; Andrea Parmeggiani; Marion Peter
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

6.  Cyclin A2 regulates homologous recombination DNA repair and sensitivity to DNA damaging agents and poly(ADP-ribose) polymerase (PARP) inhibitors in human breast cancer cells.

Authors:  Wei Wei Gu; Jie Lin; Xing Yu Hong
Journal:  Oncotarget       Date:  2017-08-24

7.  Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer.

Authors:  Xinkui Liu; Jiarui Wu; Dan Zhang; Kaihuan Wang; Xiaojiao Duan; Ziqi Meng; Xiaomeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-02       Impact factor: 2.629

8.  MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2.

Authors:  Qiang Ma
Journal:  Cell Mol Biol Lett       Date:  2019-02-05       Impact factor: 5.787

9.  Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes.

Authors:  Hangwei Fu; Jianhua Xu; Jian Chen; Guangyao Li; Xiaobiao Zhao; Ping Chen
Journal:  Mol Med Rep       Date:  2018-01-17       Impact factor: 2.952

10.  MiR-29c-3p Suppresses the Migration, Invasion and Cell Cycle in Esophageal Carcinoma via CCNA2/p53 Axis.

Authors:  Haiyong Wang; Linhai Fu; Desheng Wei; Bin Wang; Chu Zhang; Ting Zhu; Zhifeng Ma; Zhupeng Li; Yuanlin Wu; Guangmao Yu
Journal:  Front Bioeng Biotechnol       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.